"sun-pharma"

Sun Pharma Chairman Dilip Shanghvi described the Organon acquisition as both exciting and worrying due to its size and debt burden, while expressing confidence in repayment and highlighting expansion into China and biosimilars as key strategic gains

Sun Pharma will acquire US-based Organon & Co in an all-cash deal valued at USD 11.75 billion. The acquisition will strengthen its global presence, expand women’s health portfolio, and position the company among the top 25 pharmaceutical firms worldwide

The Telangana Drugs Control Administration seized counterfeit ‘Levipil 500’ tablets falsely claiming to be manufactured by Sun Pharma during raids in Hyderabad. Officials warned that spurious medicines pose serious public health risks and urged citizens to report violations.

From 30 Sensex firms, Infosys, Tech Mahindra, HCL Technologies, Sun Pharma, Tata Consultancy Services and Tata Steel were biggest gainers

Nifty midcap 100 index was up 147 points or 0.24 per cent at 60,860 and Nifty smallcap 100 index was up 37 points or 0.19 per cent at 19,586

Interpol which carries out major operations to crackdown on counterfeit medicines across several countries in the world came to know about spurious drug rackets busted by Drugs Control Administration, Telangana, through different sources.

US health regulator has directed Sun Pharma to stop trials of a dermatological drug with a 12 mg dose regimen

Hyderabad: Covid has tested and proved the credibility of the Indian pharma industry as one of the core sectors for the nation. The industry rose to the occasion by ramping up research and manufacturing to find solutions for the treatment. Pharma companies are optimistic that normalcy will return in the next one year. Speaking at […]

Hyderabad: Senior scientist from Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) Dr G R Chandak has been selected for Sun Pharma Science Foundation Research Award-2021 under the Medical Sciences-Clinical Research category. Dr Chandak is a Chief Scientist who heads a research group in CCMB that is involved in understanding the genetic basis of complex […]

New Delhi: Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection. Amid rising cases of new Covid variant Omicron in the country, an expert panel of the Central Drugs Standard Control Organisation had recently approved antiviral drug Molnupiravir for restricted use in […]

In addition, the license will also allow Sun Pharma to manufacture and sell an unlimited quantity of generic lenalidomide capsules in the US beginning January 31, 2026.

“I think our preliminary assessment indicates that vaccines will require a dedicated manufacturing facility and it cannot be produced in a facility where we are making multiple other products,” the company MD said

Dr Reddy's Laboratories is recalling 10,440 (90-count) and 2,24,710 (500 count) bottles of Atorvastatin Calcium tablets in the US market.

Sun Pharma plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price.

The 30-share BSE index pared the gains to trade 202.44 points or 0.43 per cent lower at 46,758.25.

After touching its record intra-day peak of 46,373.34, the 30-share BSE Sensex ended 154.45 points or 0.34 per cent higher at 46,253.46, its new closing record.

Similarly, the broader NSE Nifty rose 97.20 points or 0.73 per cent to an all-time closing high of 13,355.75. It touched its record intra-day peak of 13,366.65 in early trade.

The company is recalling the product due to deviation from the current good manufacturing practices (CGMP) -- detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product